story of the week
Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial
JAMA Oncol 2022 May 12;[EPub Ahead of Print], D Tripathy, SM Tolaney, AD Seidman, CK Anders, N Ibrahim, HS Rugo, C Twelves, V Diéras, V Müller, Y Du, SL Currie, U Hoch, M Tagliaferri, AL Hannah, J CortésFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.